Luzerner Kantonsspital

Futó vizsgálatok

• Toboroz

  Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)

  NCT07149649· 2/3. fázis· Swiss Cancer Institute· Forrás

• Toboroz

  Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors

  NCT07829081· University Hospital, Basel, Switzerland· Forrás

• Még nem toboroz

  FAPI PET Imaging - An Exploratory Study

  NCT07705074· 1/2. fázis· Martin Huellner· Forrás

• Még nem toboroz

  VR-based Dexterity Training in MS

  NCT07193602· Christian Kamm· Forrás

• Toboroz

  Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)

  NCT07365423· 2. fázis· Swiss Cancer Institute· Forrás

• Meghívásos bevonás

  Comparison of Blended Care Outpatient Neurorehabilitation With Traditional Outpatient Neurorehabilitation

  NCT07458308· Luzerner Kantonsspital· Forrás

• Toboroz

  Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)

  NCT07256704· Luzerner Kantonsspital· Forrás

• Toboroz

  Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial

  NCT07263438· 2. fázis· Centre Hospitalier Universitaire Vaudois· Forrás

• Toboroz

  Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  NCT06765109· 3. fázis· Nuvalent Inc.· Forrás

• Toboroz

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· 3. fázis· Amgen· Forrás

• Toboroz

  T1G3R-1 Trial: Detectability and Prognostic Value of ctDNA in T1 G3 Bladder Cancer

  NCT07581496· University Hospital, Basel, Switzerland· Forrás

• Toboroz

  A Space-expanding Shield in Decompressive Hemicraniectomy for Stroke

  NCT06638385· Insel Gruppe AG, University Hospital Bern· Forrás

• Toboroz

  Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer

  NCT07617610· Swiss Cancer Institute· Forrás

• Toboroz

  Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer

  NCT05815927· 3. fázis· European Organisation for Research and Treatment of Cancer - EORTC· Forrás

• Meghívásos bevonás

  A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice

  NCT07055607· Novo Nordisk A/S· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

  NCT06790693· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake

  NCT06571149· 4. fázis· Insel Gruppe AG, University Hospital Bern· Forrás

• Fut, nem toboroz

  REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure

  NCT06557798· The Leeds Teaching Hospitals NHS Trust· Forrás

• Toboroz

  Skin Cancer and Hyperthermia and Radiotherapy

  NCT06384053· Kantonsspital Winterthur KSW· Forrás

• Toboroz

  Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  NCT06401980· 2. fázis· Swiss Cancer Institute· Forrás

• Toboroz

  Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy

  NCT05976685· Insel Gruppe AG, University Hospital Bern· Forrás

• Toboroz

  Colchicine After Electrocardioversion for Atrial Fibrillation

  NCT05890664· 3. fázis· University Hospital, Basel, Switzerland· Forrás

• Toboroz

  Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients

  NCT06114108· Swiss Cancer Institute· Forrás

• Toboroz

  New Interactive Sensor-home-based Hand Training to Improve Dexterity

  NCT06062693· Luzerner Kantonsspital· Forrás

• Fut, nem toboroz

  Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients

  NCT05705973· Terumo Europe N.V.· Forrás

• Toboroz

  Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

  NCT05378347· Medtronic Cardiovascular· Forrás

• Fut, nem toboroz

  Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC

  NCT04630730· 2. fázis· Swiss Cancer Institute· Forrás

• Toboroz

  A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

  NCT05384626· 1/2. fázis· Nuvalent Inc.· Forrás

• Toboroz

  Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland

  NCT05819463· Swiss Society of Dermatology and Venereology· Forrás

• Toboroz

  High Dose Steroids in Children With Stroke

  NCT04873583· 3. fázis· Insel Gruppe AG, University Hospital Bern· Forrás

• Fut, nem toboroz

  A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

  NCT04965493· 3. fázis· Loxo Oncology, Inc.· Forrás

• Fut, nem toboroz

  Implementation of a Clinical Screening and Response System for Cardiac Complications After Noncardiac Surgery

  NCT05859620· University Hospital, Basel, Switzerland· Forrás

• Fut, nem toboroz

  Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

  NCT04763200· Abiomed Inc.· Forrás

• Fut, nem toboroz

  Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

  NCT04608318· 3. fázis· German CLL Study Group· Forrás

• Fut, nem toboroz

  SUCCESS (SelUtion, Safety, effiCaCy, hEalth economicS and promS) PTA Study

  NCT04776434· M.A. Med Alliance S.A.· Forrás

• Toboroz

  MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

  NCT04111978· 3. fázis· Swiss GO Trial Group· Forrás

• Toboroz

  Terumo Aortic Global Endovascular Registry

  NCT04246463· Vascutek Ltd.· Forrás

• Fut, nem toboroz

  Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial

  NCT03947619· Abiomed Inc.· Forrás

• Toboroz

  High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

  NCT04221035· 3. fázis· Gustave Roussy, Cancer Campus, Grand Paris· Forrás

• Toboroz

  Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care

  NCT04300257· Kantonsspital Winterthur KSW· Forrás

• Toboroz

  CARDSUP - SWISS Circulatory Support Registry

  NCT04117230· Insel Gruppe AG, University Hospital Bern· Forrás

• Fut, nem toboroz

  CoreHip - Post Market Clinical Follow-Up Study

  NCT03685110· Aesculap AG· Forrás

• Toboroz

  Swiss Cerebral Palsy Registry

  NCT04992871· University of Bern· Forrás

• Toboroz

  Swiss Primary Biliary Cholangitis Cohort Study

  NCT03146910· Fondazione Epatocentro Ticino· Forrás

• Fut, nem toboroz

  Prostate Cancer Biobank

  NCT04024475· Swiss Cancer Institute· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Stroke (szélütés)6 toboroz
• Tüdőrák5 toboroz
• Gyermekkori daganatok3 toboroz
• Prosztatarák3 toboroz
• Sclerosis multiplex (SM)3 toboroz
• Aortic aneurysm2 toboroz
• Elhízás2 toboroz
• Fej-nyaki daganatok2 toboroz
• Gyomor- és nyelőcsőrák2 toboroz
• Hólyagrák2 toboroz
• Pitvarfibrilláció2 toboroz
• Vastagbélrák2 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Áttétes emlőrák1 toboroz
• Cerebral palsy1 toboroz
• Endometriózis1 toboroz
• Glioblasztóma1 toboroz
• Hasnyálmirigyrák1 toboroz
• Máj- és epeúti rák1 toboroz
• Melanóma1 toboroz
• Mezotelióma1 toboroz
• Mielóma multiplex1 toboroz
• Neuroblasztóma1 toboroz
• Pajzsmirigyrák1 toboroz
• Parkinson-kór1 toboroz
• Petefészekrák1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Sarcoidosis1 toboroz
• Szarkóma1 toboroz
• Szívelégtelenség1 toboroz

Lezárt vizsgálatok

• Visszavonták

  A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight

  NCT07357766· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  SpinChip Hs-cTnI Clinical Diagnostic Performance

  NCT06499519· SpinChip Diagnostics ASA· Forrás

• Lezárult

  Emp-Activity: Empagliflozin Functional Capacity

  NCT05350202· Boehringer Ingelheim· Forrás

• Lezárult

  Neurostatus-SMARTCARE in Comparison to Standard Neurostatus-EDSS®

  NCT05575843· University Hospital, Basel, Switzerland· Forrás

• Lezárult

  Immunomodulation With Eltrombopag in ITP

  NCT04812483· 2. fázis· University Children's Hospital Basel· Forrás

• Lezárult

  A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

  NCT05259033· 3. fázis· Novo Nordisk A/S· Forrás

• Leállították

  Timing of Revascularization in Patients With Diabetic Foot Ulcer and Non-critical Peripheral Artery Disease

  NCT04939038· Insel Gruppe AG, University Hospital Bern· Forrás

• Lezárult

  A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy in Switzerland and Austria Receiving Oral Venetoclax Tablets

  NCT05215639· AbbVie· Forrás

• Lezárult

  A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome

  NCT06734117· Hoffmann-La Roche· Forrás

• Leállították

  External Validation of Two Prediction Models for Independent Gait After Stroke

  NCT05039047· Janne Veerbeek· Forrás

• Lezárult

  Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia

  NCT04864795· Vifor (International) Inc.· Forrás

• Lezárult

  Performance of 177Lu-PSMA-I&T for RLT in mCRPC - Prospective Multicenter Swiss Registry Study

  NCT06830408· University Hospital, Basel, Switzerland· Forrás

• Lezárult

  Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)

  NCT04934800· Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany· Forrás

• Lezárult

  BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma

  NCT03762018· 3. fázis· ETOP IBCSG Partners Foundation· Forrás

• Leállították

  Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL

  NCT03708003· 2. fázis· Swiss Cancer Institute· Forrás

• Lezárult

  Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry

  NCT03048825· 3. fázis· Population Health Research Institute· Forrás

• Lezárult

  Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma

  NCT03297593· 2. fázis· Swiss Cancer Institute· Forrás

• Toboroz

  Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting

  NCT03342144· AbbVie· Forrás

• Lezárult

  Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation

  NCT02950051· 3. fázis· German CLL Study Group· Forrás

• Lezárult

  Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC)

  NCT02572843· 2. fázis· Swiss Cancer Institute· Forrás

• Lezárult

  Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia

  NCT02242942· 3. fázis· Hoffmann-La Roche· Forrás

• Leállították

  Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

  NCT02051218· 3. fázis· Swiss Cancer Institute· Forrás

• Toboroz

  AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.

  NCT02102165· Jules Bordet Institute· Forrás

• Lezárult

  ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)

  NCT02078427· Baxalta now part of Shire· Forrás